Nexalin Technology, Inc. - Common Stock (NXL)
1.0200
+0.2900 (39.73%)
NASDAQ · Last Trade: Aug 24th, 11:29 AM EDT
Via Benzinga · August 22, 2025
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · August 22, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · August 22, 2025
Via Benzinga · August 22, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · August 22, 2025
Via Benzinga · August 21, 2025
The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · August 21, 2025

Via Benzinga · May 29, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Via Chartmill · May 5, 2025
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · May 5, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via Chartmill · May 5, 2025
Via Benzinga · May 2, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · April 15, 2025
Via Benzinga · April 15, 2025
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · April 4, 2025
Via Benzinga · April 4, 2025

Via Benzinga · November 11, 2024

Nexalin says the study published in the Journal of Alzheimer's Disease shows DIFS may enhance cognition in mild Alzheimer's patients.
Via Benzinga · October 28, 2024

Via Benzinga · October 25, 2024

Via Benzinga · October 25, 2024

Via Benzinga · October 17, 2024

Nexalin Technology's clinical trial results highlight notable cognitive improvements in Alzheimer's patients using Deep Intracranial Frequency Stimulation technology. The study showed significant memory and cognition gains, increased hippocampal activity, and minimal side effects.
Via Benzinga · October 17, 2024